A UK-wide Commercial Research Delivery Centre (CRDC) Network will be established thanks to a £6.5 million investment from the National Institute for Health and Care Research (NIHR), which was made possible by public-private cooperation
Glenmark Pharmaceuticals has announced its plans to launch Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials, in the United States this September. The product was determined to be bioequivalent and therapeutically equivalent...
The BaxHTN phase III trial's full results were positive; patients with hard-to-control (uncontrolled and resistant) hypertension who received baxdrostat or placebo in addition to standard of care showed a statistically significant and clinically mean
The Top 10 Indian Ayurvedic Medicine Companies that are transforming the ancient system of Ayurvedic care into modern-day solutions. These companies not only embrace Indian culture but also demonstrate that Ayurveda is the way forward in the evolving
Korber has announced the release of the new PAS-X MES 3.4, a robust upgrade to its Manufacturing Execution System that will facilitate the digital transformation of pharmaceutical manufacturing. The latest release includes a web-based and...
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, GoI, in association with the Ministry of Commerce and Industry, GoI; Export Promotion Council for Medical Devices (EPCMD), and Central Drugs Standard Control Organisation
Novo Nordisk and Apollo Clinics have signed a strategic partnership to provide a comprehensive obesity control program in multiple Indian cities
Sai Life Sciences, a Contract Research, Development, and Manufacturing Organization (CRDMO) focused on innovation, has announced the successful completion of Phase II of its new Production Block (PB-11) at the company’s primary API manufacturing
The plan to combine these separately listed businesses under the Dr. Agarwal's Group has been accepted by the boards of directors of Dr. Agarwal's Health Care Limited (AHCL) and Dr. Agarwal's Eye Hospital Limited (AEHL).
Bristol Myers Squibb presented major clinical and real-world results of its cardiovascular line at the European Society of Cardiology (ESC) Congress, which took place between August 29 and September 1, 2025, in Madrid, Spain. New data on Camzyos (mav